Literature DB >> 26385105

[Physiotherapy in rheumatology].

U Lange1.   

Abstract

Inflammatory and non-inflammatory rheumatic as well as degenerative disorders have a tendency to progress resulting in morphological and functional deficits and thus cause impairment of physical health. To inhibit this debilitating development, physiotherapeutic and exercise strategies are indispensable and in exceptional cases can be necessary for the whole lifetime. This article presents a current overview of the aims of treatment, methods and techniques, modes of action, indications and contraindications and application modalities, as well as the current underlying scientific evidence.

Entities:  

Keywords:  Evidence; Exercise therapy; Indications; Methods; Mode of action

Mesh:

Year:  2015        PMID: 26385105     DOI: 10.1007/s00393-015-1588-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  11 in total

1.  [International classification of functioning, disability and health and its significance for rheumatology].

Authors:  J Braun; J Zochling; E Grill; W Liman; G Stucki
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

Review 2.  [Evidence-based physiotherapeutic strategies for musculoskeletal pain].

Authors:  U Lange; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

Review 3.  [Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis].

Authors:  J R Kalden; H Burkhardt; B Buss; U Donhauser-Gruber; U Erstling; E Gromnica-Ihle; K Karberg; T Karger; C H Kneitz; A Krause; K Krüger; H-M Lorenz; U Müller-Ladner; A Rubbert-Roth; P Steffens-Korbanka; H-P Tony; J Wendler; J Wollenhaupt; G Burmester
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

4.  [Rehabilitation and outpatient physiotherapy in rheumatic disease patients. Results of cross-sectional studies of patients with rheumatoid arthritis or ankylosing spondylitis and rheumatologists].

Authors:  W Mau; A Müller
Journal:  Z Rheumatol       Date:  2008-11       Impact factor: 1.372

5.  Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.

Authors:  D Huscher; S Merkesdal; K Thiele; H Zeidler; M Schneider; A Zink
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

Review 6.  Exercise for osteoarthritis of the knee.

Authors:  Marlene Fransen; Sara McConnell
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 7.  Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis.

Authors:  Emalie Hurkmans; Florus J van der Giesen; Thea Pm Vliet Vlieland; Jan Schoones; E C H M Van den Ende
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

8.  [Significance and importance of physical medicine in the context of conservative therapy for rheumatic patients].

Authors:  U Lange; S Rehart
Journal:  Orthopade       Date:  2013-10       Impact factor: 1.087

Review 9.  Physiotherapy interventions for ankylosing spondylitis.

Authors:  H Dagfinrud; T K Kvien; K B Hagen
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

10.  Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low--results from RABBIT, the German biologics register.

Authors:  Joachim Listing; Anja Strangfeld; Rolf Rau; Jörn Kekow; Erika Gromnica-Ihle; Thilo Klopsch; Winfried Demary; Gerd-Rüdiger Burmester; Angela Zink
Journal:  Arthritis Res Ther       Date:  2006-04-05       Impact factor: 5.156

View more
  2 in total

Review 1.  [Physical therapy options in rheumatic diseases: what is evidence-based?]

Authors:  U Lange; S Rehart
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087

Review 2.  [Rheumatological care in the Rheumazentrum Ruhrgebiet Rheumatism Center-a model for conurbations].

Authors:  J Braun; U Kiltz; I Andreica; B Buehring; B Guminski; U Häusler; H Kavruk; D Kiefer; R Lochowski; B Mintrop; X Baraliakos
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.